
British artist and style icon Cheryl has been unveiled as the new face of NIVEA’s Cellular Epigenetics Age Rewind Serum, a breakthrough innovation featuring EPICELLINE®, developed from over 15 years of epigenetic research.
The new serum marks a milestone moment for NIVEA, harnessing cutting-edge science to visibly rewind skin’s cellular age. Combining EPICELLINE® with three molecular weights of Hyaluronic Acid, it targets ten key signs of ageing, from fine lines to firmness and radiance. In clinical trials, 93% of women reported plumper skin within seven days, and all participants confirmed a more youthful appearance after four weeks.
Speaking about the partnership, Cheryl said, “For me, NIVEA has always been trust in a bottle. This new serum is smart, gentle, and brings back that youthful glow we all love and remember.”
The campaign, directed by Masato Riesser and produced by Publicis One Touch, will run across the UK and Ireland this autumn, accompanied by an immersive Epigenetics House experience on London’s Harley Street.
Retailing at €39.99, NIVEA’s Cellular Epigenetics Age Rewind Serum is available now at major retailers including Boots and Amazon.






Leave a comment